| 3.1 Relief of overall pain ‐ dichotomous |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 3.1.1 Pelvic tenderness, partly resolved ‐ 6 months |
1 |
41 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.49, 2.73] |
| 3.1.2 Pelvic tenderness, complete resolved ‐ 6 months |
1 |
41 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.10 [0.67, 1.81] |
| 3.2 Relief of overall pain ‐ continuous |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 3.2.1 Relief of overall pain‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.30 [‐1.66, 1.06] |
| 3.2.2 Pelvic pain ‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.20 [‐0.26, 0.66] |
| 3.2.3 Dysmenorrhoea ‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.10 [‐0.49, 0.69] |
| 3.2.4 Dyspareunia ‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.20 [‐0.77, 0.37] |
| 3.2.5 Pelvic induration ‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.10 [‐0.59, 0.39] |
| 3.2.6 Pelvic tenderness ‐ 3 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.20 [‐0.78, 0.38] |
| 3.2.7 Relief of overall pain ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.40 [‐0.86, 1.66] |
| 3.2.8 Pelvic pain ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.50 [0.10, 0.90] |
| 3.2.9 Dysmenorrhoea ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.40 [‐0.12, 0.92] |
| 3.2.10 Dyspareunia ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.40 [‐0.90, 0.10] |
| 3.2.11 Pelvic induration ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
0.70 [0.21, 1.19] |
| 3.2.12 Pelvic tenderness ‐ 6 months |
1 |
41 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.20 [‐0.75, 0.35] |
| 3.3 Adverse effects ‐ dichotomous |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 3.3.1 Vaginal dryness/vaginitis ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.45 [0.52, 4.05] |
| 3.3.2 Hot flushes/flashes ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
15.50 [0.93, 259.61] |
| 3.3.3 Gastrointestinal ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.15 [0.01, 2.74] |
| 3.3.4 Weight gain ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.26 [0.08, 0.82] |
| 3.3.5 Acne ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.08 [0.00, 1.35] |
| 3.3.6 Generalised spasm ‐ 6 months |
1 |
59 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.08 [0.00, 1.35] |
